Insulin-like growth factor 1 signaling is essential for mitochondrial biogenesis and mitophagy in cancer cells by Lyons, Amy et al.
Title Insulin-like growth factor 1 signaling is essential for mitochondrial
biogenesis and mitophagy in cancer cells
Author(s) Lyons, Amy; Coleman, Michael; Riis, Sarah; Favre, Cedric; O'Flanagan,
Ciara H.; Zhdanov, Alexander V.; Papkovsky, Dmitri B.; Hursting,
Stephen D.; O'Connor, Rosemary
Publication date 2017-08-18
Original citation Lyons, A., Coleman, M., Riis, S., Favre, C., O'Flanagan, C. H.,
Zhdanov, A. V., Papkovsky, D. B., Hursting, S. D. and O'Connor, R.
(2017) 'Insulin-like growth factor 1 signaling is essential for
mitochondrial biogenesis and mitophagy in cancer cells', Journal of
Biological Chemistry, 292(41), pp. 16983-16998.
doi:10.1074/jbc.M117.792838
Type of publication Article (peer-reviewed)
Link to publisher's
version
http://dx.doi.org/10.1074/jbc.M117.792838
Access to the full text of the published version may require a
subscription.
Rights © 2017, the American Society for Biochemistry and Molecular
Biology, Inc.
Embargo information Access to this article is restricted until 12 months after publication by
request of the publisher.
Embargo lift date 2018-08-18
Item downloaded
from
http://hdl.handle.net/10468/5270
Downloaded on 2018-08-23T19:15:39Z
	 1	
Lyons et al., Supplemantary Material 
Table I 
 Sequences of oligonucleotide primers used for RT-PCR 
Primer Set Sequences 
PGC-1β F: 5’-GCTCAAGCTCTGGCTCTTCA-3’ 
R: 5’-ATGCTTGGCGTTCTGTCTGA-3’ 
PRC F: 5’-CAAGCAGAAACAGAAGAGAGAAG-3’ 
R: 5’-GGTGGGATGACAAGACAAGG-3’ 
PGC-1α F 5'-CAAGCCAAACCAACAACTTTATCTCT-3' 
R 5'-CACACTTAAGGTGCGTTCAATAGTC-3' 
NRF-2α F 5’-AACAAGAACGCCTTGGGATAC-3’ 
R 5’-GTGAGGTCTATATCGGTCATGCT-3’ 
MFN1 F 5’-TGTTTTGGTCGCAAACTCTG-3’ 
R 5’-CTGTCTGCGTACGTCTTCCA-3’ 
PINK1 5’ AGACGCTTGCAGGGCTTTC-3’ 
5’ GGCAATGTAGGCATGGTGG-3’ 
BNIP3 F 5’-CGTTCCAGCCTCGGTTTCTA-3’ 
R 5’-ATCTTGTGGTGTCTGCGAGC-3’ 
BNIP3L F 5’-AATGTCGTCCCACCTAGTCG-3’ 
R 5’-TAGCTCCACCCAGGAACTGT-3’ 
Mouse PGC-1α F 5’-AAGCACTTCGGTCATCCCTG-3’ 
R 5’-TGAGTCTCGACACGGAGAGT-3’ 
Mouse PGC-1β F 5’-GACTTGCCAGAGCTTGACCT-3’ 
R 5’-GAAGAGCTCGGAGTCATCGG-3’ 
Mouse PRC F 5’-ATCCTAAGGTCGTCAGCCCT-3’ 
R 5’-CTCTGGGAGACTAGGCCACT-3’ 
PNC1 F 5’-GCTCTGCAGCT TTTATCACAAATTC-3’ 
R 5’-AACGTAACGAGCACACTGGAGTG-3’ 
ADP/ATP trans F 5'-CCTCCTCCACACACACACAC-3' 
R 5'-GTACTCGGCTGTGCAAAACA-3' 
Aralar F 5'-CGAGACATTCCCTTCTCTGC-3' 
R 5'-GTCCCTTTCCAAAATGCTGA-3' 
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COX1 F 5'-CTCCTACTCCTGCTCGCATC-3' 
R 5'-GGGTGACCGAAAAATCAGAA-3'  
Cyto B F 5'-ATGGCTGAATCATCCGCTAC-3' 
R 5'-GTGTGAGGGTGGGACTGTCT-3' 
NFE2L2 F 5'-CTACTCCCAGGTTGCCCACA-3' 
R 5'-CGACTCATGGTCATCTACAAATGG-3' 
NRF-1 F 5'-CGCTCTGAGAACTTCATGGAGGAACAC-3' 
R 5'-GCCACATGGACCTGCTGCACT T-3' 
 	
Supplementary Table I 
List of all oligonucleotide primer sequences used for PCR in the manuscript. 
 
	  
	 3	
 
Supplementary Figure 1:  
PGC-1α, PGC-1β and PRC expression in breast cancer cell lines 
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Publically available RNA-Seq data for human cancer cell lines from the Cancer Cell Line 
Encyclopaedia was used to plot the relative expression level of PGC-1α, PGC-1β and 
PRC in a panel of breast cell lines. 
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Supplementary Figure 2:  
IGF-1 induction of mitochndrial mass and expression of PGC1 isoforms in 
different cell lines. 
A. Mitochondrial Mass in Hela, PC12, MDA-MB-231 cells, R- and R+ cells. Cells 
were serum-starved for 4 hours and stimulated with 10ng/ml or 100ng/ml IGF-1 for a 
further 20 hours. Mitochondrial mass was measured by FACS using the MitoTracker 
Green probe.   
B.  Mitochondrial Mass in TOV112D cells. A stable pool of TOV112D cells 
overexpressing IGF-1R was generated by transfection with pcDNA3-EV or pcDNA3-
IGF-1R and selection geneticin. Mitochondrial mass was measured by flow cytometry 
using the MitoTracker Green probe. Data are presented as fold difference of control 
(EV cells) set as 1. Student’s t-test *p<0.05, **p<0.01. The western blot shows 
expression of IGF-1R in TOV112D cells and that IGF-1 induces phosphorylation of 
Akt (probed with anti-IGF-1R, and anti-phospho-AKT and anti-AKT antibodies).  C. 
Western blot analysis was used to determine expression of CoxIV and VDAC in 
MCF-7 cells stimulated with IGF-1 for 24 h. D.  QPCR showing expression levels of 
PGC-1β and PRC in MDA-MB-231 cells that were either cultured in complete 
medium or seru-starved for 24 hours,  and  in R- and R+ cells cultured in complete 
medium. The expression level of each gene was normalized to the housekeeping gene, 
UBC, and the levels are shown as fold-change of the control set at 1. Data are 
presented from three independent experiments as mean ± Standard Error of the Mean 
(SEM).  Statistical Analysis for each experiment was performed using the Student’s t-
test (*P<0.05, **P<0.01). (E) Mitochondrial mass in MDA-MB-231 cells in the 
presence of the PI-3K inhibitor LY294002 (LY) or N Acetyl cysteine (NAC). Cells  
were serum starved for 4 hours and stimulated with 10ng/ml of IGF-I in presence or 
absence of inhibitors for 18 hours. Mitochondrial mass was then measured by flow 
cytometry using Mitotracker Green. The data are presented as the percentage of 
fluorescence unstimulated cells and as the mean and standard deviation from three 
separate experiments (Student T-Test  ** P<0.01). 
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Supplementary Figure 3:  
Inhibition of IGF-1R/PI-3K signalling results in reduced mitochondrial 
biogenesis 
A. Western Blot showing IGF-1R/PI-3K activity in MCF-7, MDA-MB-231, and 
ZR75.1 cells following treatment with BMS-754807. Cells were maintained in 
complete media and were treated with 500nM BMS-754807 for 24 hours. Cells were 
lysed and prepared for immunoblotting with anti-phospho-IGF-1R, anti-IGF-1R, anti-
phospho-AKT, anti-AKT, anti-phospho-P70S6K, anti-P70S6K, anti-phospho-ERK 
and anti-ERK antibodies. B. Mitochondrial mass in MCF-7 cells following MAPK 
inhibition. MCF-7 cells were treated with PD98059 for 24 hours and mitochondrial 
mass was determined by FACS analysis using the MitoTracker Green probe. C. 
QPCR showing PGC-1β and PRC expression in MCF-7 cells following treatment 
with LY294002. Cells maintained in complete media were treated with 20µM 
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LY294002 for 24 hours after which they were harvested for QPCR. PGC-1β and PRC 
levels were normalized to the housekeeping gene, UBC, and the levels are shown as 
fold-change of the control set at 1. D. QPCR showing mitochondrial gene expression 
in MCF-7 cells following treatment with BMS-754807. Cells maintained in complete 
media were treated with BMS-754807 for 24 hours after which they were harvested 
for QPCR. Expression levels of each gene was normalized to the housekeeping gene, 
UBC, and the levels are shown as fold-change of the control set at 1. E. QPCR 
showing mitochondrial gene expression in MCF-7 cells following treatment with 
LY294002. Cells maintained in complete media were treated with LY294002 for 24 
hours after which they were harvested for QPCR. Expression levels of each gene was 
normalized to the housekeeping gene, UBC, and the levels are shown as fold-change 
of the control set at 1 F. Growth rates of MCF-7 parental and MCF-7-R cells. Cells 
were initially plated at a density of 2.5x104/well of a 24-well plate and cell number 
was assessed every 24 hours by crystal violet staining. MCF-7-R cells were cultured 
in the presence of 500nM BMS-754807. Statistical Analysis for each experiment was 
performed using the Student’s t-test (*P<0.05, **P<0.01). 
 
Supplementary Figure 4:  
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IGF-1-regulated expression of  mitophagy regulatora BNIP3 FUNDC1 and 
PINK1.  
A. Western blot showing BNIP3 expression in ZR75.1 cells following stimulation 
with IGF-1. Cells were serum starved for 4 hours and stimulated with 100ng/ml IGF-
1 for 20 hours in the presence or absence of LY294002 or PD98059. Cells were then 
lysed and harvested for western blot analysis. Blots were probed with anti-BNIP3, 
anti-phospho-IGF-1R, anti-phospho-AKT, anti-AKT, anti-phospho-ERK, anti-ERK 
and anti-β-Actin antibodies. B. ZR75.1 cells were serum starved for 4 hours and 
stimulated with 100ng/ml IGF-1 for 20 hours under either normoxic or hypoxic (1% 
O2) conditions. Cells were then lysed and harvested for western blot analysis. Blots 
were probed with anti-BNIP3, anti-phospho-IGF-1R, anti-phospho-AKT, anti-AKT, 
and anti-β-Actin antibodies. C. MCF-7 cells were incubated with 20µM LY294002, 
20µM PD98059 or 500nM BMS-754807 for 24 hours. Cells were then lysed and cell 
lysates were harvested for western blot analysis. Blots were probed with anti-BNIP3, 
anti-phospho-IGF-1R, anti-phospho-AKT, anti-AKT, anti-phospho-ERK and anti-
ERK and anti-β-Actin antibodies. D. MCF-7 cells were placed in normoxia or 
hypoxia for 20 hours. Hypoxic cells were cultured in the presence or absence of 
2MeOE2. Cells were then lysed and cell lysates were harvested for western blot 
analysis. Blots were probed with anti-BNIP3 and anti-β-Actin antibodies. E. QPCR 
showing levels of BNIP3L, PINK1, and FUNDC1 following stimulation with IGF-1. 
MCF-7 cells were cultured in complete media or serum starved for 4 hours and 
stimulated with 10ng/ml or 100ng/ml IGF-1 for 24 hours in the presence or absence 
of LY294002 or PD98059. Levels of each gene was normalized to the housekeeping 
gene, UBC, and the levels are shown as fold-change of the control set at 1 Data is 
included from three separate experiments. 
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Supplementary Figure 5:  
MCF-7-R cells display increased sensitivity to glycolysis inhibition compared to 
parental cells.  
A. MCF-7 and MCF-7-R cells were seeded into colony formation assays and 
incubated with concentrations of 2-DG (1mm-10mM) and allowed to grow for 14 
days. The drug was replenished every 4 days. Cells were fixed and stained with 
crystal violet. Odyssey Infrared Imaging system was used to image the assay. Data 
presented on the graph are the average +/- SEM of triplicate wells of two individual 
experiments. B. Representative immunoblot of MCF-7 parental and MCF-7-R cells 
treated with BMS-754807, 2-DG, or both in combination. Cells were treated with 
500nM BMS-754807 or 25mM 2-DG for 24 hours in complete culture media before 
being harvested for western blot analysis. The blot was probed anti-phospho-AKT, 
anti-AKT, and anti-β-Actin antibody.  	
